<DOC>
	<DOCNO>NCT01948921</DOCNO>
	<brief_summary>Our pilot result show meperidine reduce patient discomfort EGD ( esophagogastroduodenoscopy ) . But many patient tolerate EGD well without sedative agent . So investigator target use meperidine patient expect poor tolerance study , includ young female high anxiety level patient prior poor tolerance . The investigator test hypothesis meperidine improve tolerance alleviates discomfort patient expect poor tolerance diagnostic EGD .</brief_summary>
	<brief_title>Meperidine Patients Expected Have Poor Tolerance During Diagnostic Esophagogastroduodenoscopy .</brief_title>
	<detailed_description />
	<mesh_term>Meperidine</mesh_term>
	<criteria>female youger 65 year high anxiety level patient previous poor tolerance EGD therapeutic EGD sedation agent contraindication Buscopan ( hyoscine Nbutylbromide ) meperidine American Society Anesthesiology ( ASA ) risk Class 3 high , renal failure age le 20 year 80 year pregnancy refusal provide write informed consent . All participant sign write informed consent</criteria>
	<gender>All</gender>
	<minimum_age>20 Years</minimum_age>
	<maximum_age>80 Years</maximum_age>
	<verification_date>March 2017</verification_date>
	<keyword>EGD</keyword>
	<keyword>tolerance</keyword>
	<keyword>discomfort</keyword>
</DOC>